University of Lausanne

University of Lausanne
Université de Lausanne, 1015 Lausanne
University of Lausanne  
Location: Lausanne
Affiliation: swissuniversities
Related:
Health - Feb 15
Cameron S. McAlpine, Màté G. Kiss, Sara Rattik, Shun He, Anne Vassalli, Colin Valet, Atsushi Anzai, Christopher T. Chan, John E. Mindur, Florian Kahles, Wolfram C. Poller, Vanessa Frodermann, Ashley M. Fenn, Annemijn F. Gregory, Lennard Halle, Yoshiko Iwamoto, Friedrich F. Hoyer, Christoph J. Binder, Peter Libby, Mehdi Tafti, ..
Health - Feb 15

Simon. Plummer, Stephanie Wallace, Graeme Ball, Roslyn Lloyd, Paula Schiapparelli, Alfredo Quinones-Hinojosa, Thomas Hartung, David Pamies A high throughput histology (micro TMA) platform waas applied for testing drugs against tumors in a novel 3D heterotypic glioblastoma brain sphere (gBS) model c

Administration - Feb 14
Administration

With the dawning of the second semester of the academic year 2018/2019, HEC Lausanne is pleased to announce the appointment of seven new professors for its departments of Information Systems, Finance, and Operations.

Business - Feb 14
Business

Professor Benjamin Mueller will join the Department of Information Systems at HEC Lausanne, University of Lausanne on February 1st, 2019, as an Associate Professor.

Business - Feb 14

Marc-Olivier Boldi joined the Department of Operations at HEC Lausanne, University of Lausanne on February 1st, 2019, as a Senior Lecturer. Marc-Olivier Boldi has a general expertise in applied statistics, machine learning and data science.

Business - Feb 14

Johan Walden joined the Department of Finance at HEC Lausanne, University of Lausanne on January 1st, 2019, as Full Professor. Johan Walden holds a Ph.D. in financial economics from Yale University (United States) and a Ph.D.

Health - Feb 13

Ping-Chih Ho, of the Ludwig Institute for Cancer Research Lausanne, and his team discover a possible way of outsmarting melanomas that currently elude immune checkpoint blockade therapy. Pr Ho and his team have uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.




website preview